Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 9, 2004, Pages 1515-1521

  Moake, J L ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER; RISTOCETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD SAMPLING; DNA POLYMORPHISM; ENDOTHELIUM INJURY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE AGGLUTINATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ANIMALS; AUTOBIOGRAPHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; METALLOENDOPEPTIDASES; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, QUATERNARY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; UNITED STATES; VON WILLEBRAND FACTOR;

EID: 8844248794     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00905.x     Document Type: Article

References (33)

1. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977; 297: 1386-9.
2. Lian EC, Harkness DR, Byrnes JJ, Wallach H, Nunez R. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood 1979; 53: 333-8.
3. Lian EC, Savaraj N. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura. Blood 1981; 58: 354-9.
4. Nachman RL, Jaffe EA, Ferris B. Multiple molecular forms of endothelial cell factor VIII related antigen. Biochem Biophys Acta 1981; 667: 361-9.
5. Schulman I, Pierce M, Lukens A, Currimbhoy Z, Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency. Blood 1960; 16: 943-57.
6. Upshaw JD. Congenital deficiency of a factor in plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med 1978; 298: 1350-2.
7. Veyradier A, Lavergne JM, Ribba AS, Obert B, Loirat C, Meyer D, Girma JP, Ten candidate mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). J Thromb Haemost 2004; 2: 424-9.
8. Matsumoto M, Kokame K, Soejima K, Miura M, Hayashi S, Fujii Y, Iwai A, Ito E, Tsuji Y, Takeda-Shitaka M, Iwadate M, Umeyama H, Yagi H, Ishizashi H, Banno F, Nakagaki T, Miyata T, Fujimura Y. Molecular characterization of ADAMTS13 mutations in Japanese patients with Upshaw-Schulman syndrome. Blood 2004; 103: 1305-10.
9. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII. von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Eng J Med 1982; 307: 1432-5.
10. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924; 24: 21-4.
11. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM. Effects of fresh frozen plasma and its cryosupernatant fraction on von Willebrand factor multimer forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1985; 65: 1232-6.
12. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989; 87: 9N-14N.
13. Chintagumpala M, Hurwitz R, Moake J, Mahoney D, Steuber C. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr 1992; 120: 49-53.
14. Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, Santiago-Borrero P, Horowitz M, Pehta J. Solvent/detergent-treated plasma contains the component that reverses von Willebrand factor-mediated shear-induced platelet aggregation and prevents episodes of chronic relapsing thrombotic thrombocytopenic purpura. Blood 1994; 84: 490-7.
15. Chow TW, Turner NA, Chintagumpala M, McPherson PD, Nolasco LH, Rice L, Hellums JD, Moake JL. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 1998; 57: 293-302.
16. Lian EC, Siddiqui FA. Investigation of the role of von Willebrand factor in in thrombotic thrombocytopenic purpura. Blood 1985; 66: 1219-21.
17. Tsai HM, Lian EC. Antibodies of von Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
18. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-94.
19. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-103.
20. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. N Engl J Med 1998; 339 1578-84.
21. Moake JL. Moschcowitz, multimers and metalloprotease. N Eng J Med 1998; 339: 1629-31.
22. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98: 1654-61.
23. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98: 1662-6.
24. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor cleaving protease (ADAMTS13), a metaloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 41059-63.
25. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma vWF multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-61.
26. Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, Lopez JA. Ultra-large multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet GP Ib-IX complex: studies using optical tweezers. Blood 2002; 99: 3971-7.
27. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, López JA. ADAMTS-13 rapidly cleaves newly secreted ultra-large von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-9.
28. Bernardo A, Ball C, Nolasco L, Moake JL, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelialcell-derived ultra-large von Willebrand factor multimers under flow. Blood. 2004; 104: 100-6.
29. Padilla A, Moake J, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Turner N, Berndt MC, Anvari B, Lopez J, Dong JF. P-selectin anchors newly released ultra-large von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150-6.
30. Dong JF, Moake JL, Bernardo A, Fujikawa K, Ball C, Nolasco L, Lopez JA, Cruz MA. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem 2003; 278: 296339.
31. Whitelock JL, Nolasco LN, Bernardo A, Moake JL, Dong JF, Cruz MA. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate. J Thromb Haemost 2004; 2: 485-91.
32. Moake JL. von Willebrand factor abnormalities in thrombotic thrombocytopenic purpura and the hemolytic - uremic syndrome. In: Hemolytic - Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. BS Kaplan, RS Trompeter, JL Moake, eds. Marcel Dekker, Inc. New York, NY, 1992: p 459.
33. Moake JL. Haemolytic - uraemic syndrome: basic science. Lancet 1994; 343: 393-7.